COVID-19: "Reactive" Vaccination, Effective in Case of High Viral Circulation? - Inserm Newsroom
A PD-L1-Based Cancer Vaccine Elicits Antitumor Immunity in a Mouse Melanoma Model: Molecular Therapy - Oncolytics
BDP International - Today Francisco Rizzuto and Maurizio Zanetti will join BDP team members for an interactive discussion about the air cargo industry including COVID-19 response, strategies to keep cargo flowing, and
Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model | Scientific Reports
Full article: Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response
Vaccines | Free Full-Text | Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures - eClinicalMedicine
T cell memory and protective immunity by vaccination: is more better?: Trends in Immunology
Hepatitis B vaccine - Wikipedia
Cells | Free Full-Text | Vaccination in Atherosclerosis
Vaccines | Free Full-Text | A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
Effectiveness of Hepatitis B Vaccination in Babies Born to Hepatitis B Surface Antigen-Positive Mothers in Italy
Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination | npj Vaccines
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, rand
Vaccines | Free Full-Text | COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review
Full article: Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn – outcome of a cross-sectional conjoint experiment in Spain and Italy
Untitled
Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 | Nature Communications
Bridging the knowledge gaps in vaccine design | Nature Biotechnology
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges - ScienceDirect
A novel COVID-19 vaccine using modified bacterial DNA – Global Health Press
Segafredo Zanetti Shot Glass - 2.5 oz
Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen | Nature Communications
A Novel COVID-19 Vaccine Using Modified Bacterial DNA
